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Abstract Both free and hidden natural antibodies to DNA or 
cardiolipin were obtained from immunoglobulins of a normal 
donor. The free antibodies reacting with DNA or cardiolipin were 
isolated by means of affinity chromatography. Antibodies 
occurring in an hidden state were disengaged from the depleted 
immunoglobulins by ion-exchange chromatography and were 
then affinity-isolated on DNA or cardiolipin sorbents. We used 
flow cytometry to study the ability of free and hidden antibodies 
to bind to rat thymocytes. Simultaneously, plasma membrane 
integrity was tested by propidium iodide (PI) exclusion. The 
hidden antibodies reacted with 65.2 ± 10.9% of the thymocytes 
and caused a fast plasma membrane disruption. Cells 
(28.7 ± 7.1%) were stained with PI after incubation with the 
hidden antibodies for 1 h. The free antibodies bound to a very 
small fraction of the thymocytes and did not evoke death as 
compared to control without antibodies. The possible reason for 
the observed effects is difference in reactivity of the free and 
hidden antibodies to phospholipids. While free antibodies reacted 
preferentially with phosphotidylcholine, hidden antibodies re-
acted with cardiolipin and phosphotidylserine. 
© 1997 Federation of European Biochemical Societies. 
Key words: Flow cytometry; Cell death; Natural antibody; 
Hidden antibody; Antibody to D N A ; 
Antibody to cardiolipin; Ra t thymocyte 
1. Introduction 
In recent years the problems of natural antibodies (origin, 
functions, activity regulation) [1,2] have attracted considerable 
interest. 
Natura l antibodies are an obligatory component of normal 
immunity. They have been found in blood plasma of healthy 
individuals and animals. In addition, up to 30% of hybrid-
omas that can be obtained from healthy individuals produce 
natural antibodies [3]. 
The most characteristic feature of natural antibodies is their 
polyspecificity. They react with D N A , phospholipids, proteins 
of cytoskeleton and proteins of plasma membrane. Perhaps, 
the reason for polyspecificity is the ability of natural antibod-
ies to react with various antigens via electrostatic interaction 
[4-6]. 
In our previous studies it was shown that a significant 
amount of antibody to D N A and to cardiolipin is in a hidden 
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state and its activity is displayed only after treatment by ion-
exchange chromatography on QAE-Sephadex or gel filtration 
at p H 4.5 [5]. These data have been confirmed by other re-
searchers [7,8]. 
Functions of natural antibodies are widely discussed. How-
ever, there are no data regarding the possible functions of 
hidden antibodies described in our studies. It is known that 
an t i -DNA antibodies (derived from patients with systemic lu-
pus erythematosis) is able to interact with various types of 
membranes and evoke the death of mesangial and endothelial 
cells [9-11]. Taking this into account, in a number of features, 
hidden antibodies to D N A are similar to those known for 
lupus antibodies. Thus, it would be interesting to investigate 
the analogous properties of hidden antibodies. 
In the present study, the ability of hidden antibodies to 
react with T-cells and evoke their death is investigated. 
2. Materials and methods 
10% Normal human y-globulin (yG) solution produced for intra-
muscular administration (Moscow Research Institute of Epidemiology 
and Microbiology; the technological procedure of manufacturing in-
volves the alcohol fractionation of serum proteins according to Cohn), 
'Sandoglobulin' (normal human immunoglobulins for intravenous in-
fusion; Sandoz Pharm. Ltd., Switzerland) were used as the source of 
antibodies. 
2.1. Antibody isolation 
yG preparations were diluted in 0.1 M phosphate-buffered solution 
(PBS; 10-12 mg/ml), recirculated for 16-18 h on an affinity column 
containing DNA or cardiolipin sorbents and the fraction of absorbed 
yG (free antibodies) was eluted with 2 M NaCl. The procedure was 
repeated several times until the complete removal of antibodies which 
bound DNA or cardiolipin from yG. The depleted yG was dialyzed 
against 0.01 M potassium phosphate buffer (pH 7.3) and mixed with 
QAE-Sephadex A-50 beads (1 ml of gel/5 mg protein) in the same 
buffer for 1.5 h. The slurry was packed into a column and two frac-
tions were eluted with 0.01 M potassium phosphate buffer and with 
0.5 M NaCl. Antibodies to DNA or to cardiolipin from these frac-
tions (so-called hidden antibodies) were isolated on the corresponding 
affinity columns. Antibodies were dialyzed against 0.01 M PBS and 
concentrated. Protein concentration was determined by Bradford's 
assay. 
Interaction of the antibodies with different phospholipids was as-
sessed by ELISA as described [12]. 
2.2. Thymocyte isolation, incubation and staining 
Cells were isolated from thymus of young rats (3^1 weeks old) by 
rubbing through a nylon mesh and thereafter washing with 0.01 M 
PBS, pH 7.2. The thymocytes (5-10° cells) were incubated with 20 u.g 
of either free or hidden antibodies in 1 ml of PBS containing 0.5% 
bovine serum albumin (BSA, Sigma) for 1 h at 37°C. To determine 
the dependence of binding and cell death on antibody concentration, 
we used 1^40 ug/ml of free or hidden antibodies. After treatment, cells 
were washed 2 times with PBS/BSA and then incubated with FITC-
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labeled antibodies to human IgG (Sigma Chemical Co., USA) for 1 h 
at 37°C. Then the thymocytes were washed, resuspended in PBS and 
stained with PI (Sigma Chemical Co., 40 ng/ml) for 10 min at room 
temperature before beginning flow cytometry. 
To determine the dependence of cell death on incubation time with 
antibodies, thymocytes were incubated with 20 ug of antibodies for 
5 min to 3 h at 37°C, then washed with PBS and stained with PI for 
10 min. 
To determine DNA fragmentation, after 1 h treatment with free or 
hidden antibodies (20 ug/5-106 cells) cells were lysed with 0.2% Triton 
X-100, 4 mM Tris-HCl, 1 mM EDTA (pH 7.5) for 5 min. After 
centrifugation at 6000 Xg for 5 min, the fraction of fragmented 
(supernate) DNA was evaluated fluorimetrically using Hoechst 
33258 (2 uM). 
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Fig. 1. Typical histograms of the binding of hidden antibodies (A), 
free antibodies (B) to the thymocytes and control sample incubated 
only with FITC-labeled antibodies to human Ig (C). Abscissa: 
FITC fluorescence intensity; ordinate: number of cells. 
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Fig. 2. Ordinate: PI fluorescence in thymocytes after treatment with 
hidden antibodies (A), free antibodies (B) and in control sample 
without primary antibodies (C). Abscissa: Forward scatter values. 
2.3. Flow cytometry 
Samples were analyzed on FACS Vantage flow cytometer (Becton 
Dickinson Immunocytometry Systems, CA) equipped with argon ion 
laser Enterprise 621 (Coherent, CA) operating at 488 nm (150 mW). 
FITC and PI fluorescences were collected with 530/30 and 582/42 nm 
filters, respectively. Twenty-thousand events were analyzed for each 
sample. Data acquisition and analysis were performed with a Hewlett-
Packard 340 computer using 'Lysys II' software (Becton Dickinson). 
After gating on a cytogram of light scatter to exclude cell clumps 
and debris, a cytogram of PI fluorescence versus forward light scatter 
was recorded to determine the fraction of cells which included PI due 
to loss of plasma membrane integrity. The fraction of cells binding 
antibodies and mean fluorescence intensity of labeled cells were esti-
mated using FITC fluorescence histograms after exclusion of clumps 
and debris. 
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Fig. 3. Dependence of number of PI-positive cells (•), cells binding antibodies (■) and mean fluorescence intensity of labeled cells (♦) on the 
hidden antibody concentration. Dependence of number of Pi-positive cells (o) and cells binding antibodies (□) on the free antibody concentra-
tion. 
3. Results 
The intensity of binding of the free antibody to DNA ob-
tained from immunoglobulin preparations and the hidden 
antibody to the thymocytes is shown in Fig. 1 as histograms. 
70% of thymocytes bind the hidden antibodies and fall into 
region Ml . Not more than 5% of cells fall into Ml after 
treatment with the free antibodies or in the control sample 
without primary antibodies (Table 1). 
Fig. 2 is a contour plot which allows determination of the 
fraction of cells stained with PI. The cells localized to Rl 
region were characterized by bright PI fluorescence and re-
ferred to as dead. No effect of free antibodies on cell death 
was observed, whereas incubation of thymocytes with hidden 
antibodies brought about pronounced elevation in the number 
of dead cells (Table 1). We did not observed DNA fragmen-
tation after treatment with hidden antibodies in the fluoro-
metric test with Hoechst 33258 (data not shown). 
We also studied the dependence of the effects on antibody 
concentration (1^40 |Xg/ml). The results of a typical experi-
ment are shown in Fig. 3. Increase in concentration of hidden 
antibodies did not appreciably change the fraction of cells 
binding antibody, while a significant increase in fluorescence 
of labeled cells was observed. Augmentation of Pi-positive cell 
number correlated with the mean fluorescence intensity of 
labeled cells (r = 0.98). 
Dependence of the cell death on incubation time with anti-
bodies to DNA is shown in Fig. 4. Hidden antibodies evoked 
fast plasma membrane disruption in 14.0% of the thymocytes 
during 30 min; free antibodies had no effect. 
Thus, an essential distinction was found between free and 
hidden antibodies to DNA in their ability to bind to thymo-
cyte surface as well as to cause their death. Similar results 
were observed with affinity purified hidden antibodies to car-
diolipin (data not shown). 
ELISA data in Table 2 show that there is a difference in the 
ability of free and hidden antibodies to react with phospho-
lipids. Free antibodies reacted preferentially with phospho-
tidylcholine whereas hidden antibodies reacted with cardio-
lipin and phosphotidylserine. 
4. Discussion 
Free antibodies reacting with DNA or cardiolipin were iso-
lated by means of affinity chromatography. Antibodies occur-
ring in a hidden state were disengaged from the depleted im-
Table 1 
Summary of the flow cytometric analyses of thymocytes treated with free and hidden antibodies (20 u.g/ml) 
Antibodies Fraction of cells binding antibodies 
(% ±SD) 
Fraction of Pi-positive cells 
(% ±SD) 
Control without primary antibodies 
Free antibodies 
Hidden antibodies 
5.6 ± 2.2 
65.2 ±10.9 
3.2 ±0.9 
3.3 ±0.9 
28.7±7.1 
Results shown are averages of five experiments. 
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Fig. 4. Dependence of Pi-positive cell number on the time of incubation with hidden antibodies (■), free antibodies (♦) to DNA and in con-
trol samples without primary antibodies (•). 
munoglobulins by ion-exchange chromatography and were 
then affinity isolated on DNA or cardiolipin sorbents. The 
amount of hidden antibodies was 4-5-fold greater than that 
of the free antibodies. It was shown that only hidden anti-
bodies interacted with thymocytes and caused the death of 
their pronounced fraction. 
A form of cell death evoked by hidden antibodies is not yet 
definitively clear. It is known that a critical event in apoptosis 
is the increase in cytosolic Ca2+ due to internal mobilization 
and influx of extracellular Ca2+ [13,14]. Preliminary data were 
obtained regarding a profound elevation of the membrane 
permeability towards 45Ca (a 2-fold increase in the initial 
rate of Ca2+ uptake) observed within the same time span (pa-
per in preparation). However, within 1 h when we clearly ob-
served the Pi-detectable death of a significant number of cells, 
there was no DNA fragmentation characteristic of apoptosis. 
Investigation of free and hidden Ab properties revealed that 
the ability to react with phosphohpids is essentially diverse; 
free antibodies reacted preferentially with phosphotidylcholine 
whereas hidden antibodies reacted with cardiolipin and phos-
photidylserine. Apparently, the most important role in epitope 
formation is determined by the presence of a positive or neg-
ative charge. 
It is significant that the killer antibodies causing cell death 
exist in the hidden state that may indicate the presence of 
some system which prevents the cytotoxic effect of this anti-
body. Appearance of killer antibodies in a free state may 
result from an inability of serum to suppress its activity. We 
have found that the appearance of antibodies with similar 
properties may occur under traumatic or burn shock condi-
tions [15]. 
Hidden antibodies to DNA or to cardiolipin binding to the 
thymocytes and causing their death is likely to play an im-
portant role in maintaining homeostasis. Investigation of the 
cytotoxic effect mechanisms of hidden antibodies is in prog-
ress. 
Table 2 
Interaction of the free and hidden antibodies (50 ug/mi) with phosphohpids (OD492) 
Antibodies Cardio-
lipin 
Phosphotidyl- Phosphotidyl-
choline 
Cardiolipin/phospho-
tidylcholine 
Phosphotidylserine/phospho-
tidilcholine 
ree antibodies to DNA 
idden antibodies to DNA 
ree antibodies to cardiolipin 
idden antibodies to cardiolipin 
0.37 
1.53 
0.11 
0.65 
0.66 
1.33 
0.12 
0.87 
0.95 
0.36 
0.15 
0.10 
0.39 
4.25 
0.73 
6.50 
0.69 
3.69 
0.80 
8.70 
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